In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK FMD (foot and mouth disease) animal restrictions lifted but tissue technology industry awaits:

This article was originally published in Clinica

Executive Summary

At the time of going to press, Clinica was awaiting confirmation from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) regarding possible changes to restrictions imposed on the trade of medical devices containing material sourced from biungulate animals, in light of the outbreaks of foot and mouth disease (FMD) in southern England earlier this month. Despite the early lifting of some restrictions on the movement and international trade of animals and products, an agency spokesperson could not confirm, on the eve of going to press, whether there had been any change to the situation, as set out in its August 14 notice (see Clinica No 1269, p 5).






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts